Portal Innovations Expands to South Boston
March 29 2023 - 10:00AM
Business Wire
Partners with ZoE Life Sciences / Beacon
Capital to Operate State-of-the-Art Lab Space and Invest in
Bioscience Startups at Southline
Portal Innovations, a leading life sciences venture development
engine, announced today that it will be expanding its operations to
South Boston in April, 2023. The Company, which specializes in
early-stage life sciences venture creation and investments, will be
launching its initial lab and office space in the Southline Boston
building.
"We are excited to bring our unique business model to an
emerging part of the Boston life science ecosystem," said John
Flavin, Founder and CEO of Portal Innovations. “Boston is home to
world-class universities, premier life sciences venture capital
firms, and an unsurpassed pool of diverse talent. Portal is eager
to support entrepreneurs and founders by providing its Crafted
Capital model of seed capital investment, access to strategic lab
space, and management expertise to de-risk these early-stage
ventures.”
Portal’s initial space at Southline Boston will consist of
22,000 SF of high-end wet lab and office space to facilitate growth
for companies fundraising between Seed to Series B rounds, and will
expand its footprint to 58,000 SF in the first half of 2024. Portal
is partnering with Boston-based Beacon Capital and ZoE Life
Sciences in a joint venture to build out the space and invest in
promising life sciences companies.
“Massachusetts is unmatched in its life sciences research and
development, and we join in Portal’s excitement about the promise
that Boston’s neighborhoods bring to growing the industry and
supporting innovation,” said Jason Cordeiro, MassBio Chief
Operating Officer. “Southline Boston and Portal’s new space will
deliver more opportunities for emerging biotech entrepreneurs and
startups to advance their patient-driven science, be successful in
their business, and contribute to the larger ecosystem.”
The Southline project is located in the former Boston Globe
building off of the JFK/UMass Red Line “T” stop, near I-93,
providing members with a variety of transportation options across
the city.
"Boston is the leading hub for biomedical innovation and we're
thrilled to partner with Portal to support early-stage venture
firms and their portfolio companies,” said Fred Seigel, CEO of
Beacon Capital. “Offering a fully developed life sciences ecosystem
in a single building will catalyze the next phase of Boston’s
impact on life sciences."
The entire Southline project will encompass over 700,000 square
feet, primarily dedicated to opening an attractive option for life
sciences companies starting and scaling in the South Boston area.
The project has a food hall, gym, roof deck, brewpub, and a number
of other amenities with a campus vibe, seeking to attract
world-class biosciences talent in the area.
Portal Innovations is a premier venture development engine with
a presence in Chicago, Atlanta, and Boston, that bridges scientific
ideation in life sciences through commercial proof of concept by
delivering Crafted Capital, including seed funding, specialized
equipment, lab space, and management expertise to high-potential
early-stage companies.
Beacon Capital Partners (“Beacon”) is a leading private real
estate investment firm, owning and operating office and life
science properties. The firm has a 75-year legacy of successful
real estate development, management, and transformation of
workplaces. For more information, please visit
www.beaconcapital.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230329005185/en/
For more information, please visit www.portalinnovations.com.
Media Contact: Nick Pennebaker, Director of Marketing Media Email:
nick.pennebaker@portalinnovations.com To Apply to Portal
Innovations Membership:
http://23230704.hs-sites.com/portal-boston